|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rivera C and Venegas B: Histological and
molecular aspects of oral squamous cell carcinoma (Review). Oncol
Lett. 8:7–11. 2014.PubMed/NCBI
|
|
3
|
Nagpal JK, Patnaik S and Das BR:
Prevalence of high-risk human papilloma virus types and its
association with P53 codon 72 polymorphism in tobacco addicted oral
squamous cell carcinoma (OSCC) patients of Eastern India. Int J
Cancer. 97:649–653. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang J, Jia L, Kuang Z, Wu T, Hong Y, Chen
X, Leung WK, Xia J and Cheng B: The in vitro and in vivo antitumor
effects of clotrimazole on oral squamous cell carcinoma. PLoS One.
9:e988852014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Johnson NW, Jayasekara P and Amarasinghe
AA: Squamous cell carcinoma and precursor lesions of the oral
cavity: Epidemiology and aetiology. Periodontol 2000. 57:19–37.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuan P, Temam S, El-Naggar A, Zhou X, Liu
DD, Lee JJ and Mao L: Overexpression of podoplanin in oral cancer
and its association with poor clinical outcome. Cancer.
107:563–569. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Forastiere A, Koch W, Trotti A and
Sidransky D: Head and neck cancer. N Engl J Med. 345:1890–1900.
2001. View Article : Google Scholar
|
|
9
|
Sano D and Myers JN: Metastasis of
squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev.
26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Silverman S Jr: Demographics and
occurrence of oral and pharyngeal cancers. The outcomes, the
trends, the challenge. J Am Dent Assoc. 132(Suppl): S7S–S11. 2001.
View Article : Google Scholar
|
|
11
|
Gervásio OL, Dutra RA, Tartaglia SM,
Vasconcellos WA, Barbosa AA and Aguiar MC: Oral squamous cell
carcinoma: A retrospective study of 740 cases in a Brazilian
population. Braz Dent J. 12:57–61. 2001.PubMed/NCBI
|
|
12
|
Bundgaard T, Bentzen SM and Wildt J: The
prognostic effect of tobacco and alcohol consumption in intra-oral
squamous cell carcinoma. Eur J Cancer B Oral Oncol. 30B:323–328.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lissowska J, Pilarska A, Pilarski P,
Samolczyk-Wanyura D, Piekarczyk J, Bardin-Mikolłajczak A, Zatonski
W, Herrero R, Munoz N and Franceschi S: Smoking, alcohol, diet,
dentition and sexual practices in the epidemiology of oral cancer
in Poland. Eur J Cancer Prev. 12:25–33. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou JM, Zhu XF, Pan QC, Liao DF, Li ZM
and Liu ZC: Manumycin inhibits cell proliferation and the Ras
signal transduction pathway in human hepatocellular carcinoma
cells. Int J Mol Med. 11:767–771. 2003.PubMed/NCBI
|
|
15
|
Frassanito MA, Cusmai A, Piccoli C and
Dammacco F: Manumycin inhibits farnesyltransferase and induces
apoptosis of drug-resistant interleukin 6-producing myeloma cells.
Br J Haematol. 118:157–165. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Di Paolo A, Danesi R, Nardini D, Bocci G,
Innocenti F, Fogli S, Barachini S, Marchetti A, Bevilacqua G and
Del Tacca M: Manumycin inhibits ras signal transduction pathway and
induces apoptosis in COLO320-DM human colon tumour cells. Br J
Cancer. 82:905–912. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li JG, She MR, Lu CY, Wei SS, Xia PF, Lu
ZS and Peng Q: Manumycin induces apoptosis in prostate cancer
cells. Onco Targets Ther. 7:771–777. 2014.PubMed/NCBI
|
|
18
|
Xiong Q and Rikihisa Y: The prenylation
inhibitor manumycin A reduces the viability of Anaplasma
phagocytophilum. J Med Microbiol. 60:744–749. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Devanand P, Kim SI, Choi YW, Sheen SS, Yim
H, Ryu MS, Kim SJ, Kim WJ and Lim IK: Inhibition of bladder cancer
invasion by Sp1-mediated BTG2 expression via inhibition of DNA
methyltransferase 1. FEBS J. 281:5581–5601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Krishnan V, Wang X and Safe S: Estrogen
receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene
expression in MCF-7 human breast cancer cells. J Biol Chem.
269:15912–15917. 1994.PubMed/NCBI
|
|
21
|
Chuang CW, Pan MR, Hou MF and Hung WC:
Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated
phosphorylation and activation of Sp1 in breast cancer cells. J
Cell Physiol. 228:341–348. 2013. View Article : Google Scholar
|
|
22
|
Banerjee S, Sangwan V, McGinn O, Chugh R,
Dudeja V, Vickers SM and Saluja AK: Triptolide-induced cell death
in pancreatic cancer is mediated by O-GlcNAc modification of
transcription factor Sp1. J Biol Chem. 288:33927–33938. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo MM, Hu LH, Wang YQ, Chen P, Huang JG,
Lu N, He JH and Liao CG: miR-22 is down-regulated in gastric
cancer, and its overexpression inhibits cell migration and invasion
via targeting transcription factor Sp1. Med Oncol. 30:5422013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Singha PK, Pandeswara S, Venkatachalam MA
and Saikumar P: Manumycin A inhibits triple-negative breast cancer
growth through LC3-mediated cytoplasmic vacuolation death. Cell
Death Dis. 4:e4572013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Courey AJ and Tjian R: Analysis of Sp1 in
vivo reveals multiple transcriptional domains, including a novel
glutamine-rich activation motif. Cell. 55:887–898. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu S and Archer MC: Sp1 coordinately
regulates de novo lipogenesis and proliferation in cancer cells.
Int J Cancer. 126:416–425. 2010. View Article : Google Scholar
|
|
27
|
Opitz OG and Rustgi AK: Interaction
between Sp1 and cell cycle regulatory proteins is important in
transactivation of a differentiation-related gene. Cancer Res.
60:2825–2830. 2000.PubMed/NCBI
|
|
28
|
Wang L, Wei D, Huang S, Peng Z, Le X, Wu
TT, Yao J, Ajani J and Xie K: Transcription factor Sp1 expression
is a significant predictor of survival in human gastric cancer.
Clin Cancer Res. 9:6371–6380. 2003.PubMed/NCBI
|
|
29
|
Yamaguchi H and Wang HG: CHOP is involved
in endoplasmic reticulum stress-induced apoptosis by enhancing DR5
expression in human carcinoma cells. J Biol Chem. 279:45495–45502.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shimizu S, Narita M and Tsujimoto Y: Bcl-2
family proteins regulate the release of apoptogenic cytochrome c by
the mitochondrial channel VDAC. Nature. 399:483–487. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado
AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by
Bcl-2: Release of cytochrome c from mitochondria blocked. Science.
275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sankpal UT, Goodison S, Abdelrahim M and
Basha R: Targeting Sp1 transcription factors in prostate cancer
therapy. Med Chem. 7:518–525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chintharlapalli S, Papineni S, Ramaiah SK
and Safe S: Betulinic acid inhibits prostate cancer growth through
inhibition of specificity protein transcription factors. Cancer
Res. 67:2816–2823. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jutooru I, Chadalapaka G, Sreevalsan S,
Lei P, Barhoumi R, Burghardt R and Safe S: Arsenic trioxide
downregulates specificity protein (Sp) transcription factors and
inhibits bladder cancer cell and tumor growth. Exp Cell Res.
316:2174–2188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi ES, Cho SD, Jeon JG and Cho NP: The
apoptotic effect of the hexane extract of Rheum undulatum L. in
oral cancer cells through the down-regulation of specificity
protein 1 and survivin. Lab Anim Res. 27:19–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bhat UG, Halasi M and Gartel AL: Thiazole
antibiotics target FoxM1 and induce apoptosis in human cancer
cells. PLoS One. 4:e55922009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Basso AD, Solit DB, Munster PN and Rosen
N: Ansamycin antibiotics inhibit Akt activation and cyclin D
expression in breast cancer cells that overexpress HER2. Oncogene.
21:1159–1166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nakano K, Mizuno T, Sowa Y, Orita T,
Yoshino T, Okuyama Y, Fujita T, Ohtani-Fujita N, Matsukawa Y,
Tokino T, et al: Butyrate activates the WAF1/Cip1 gene promoter
through Sp1 sites in a p53-negative human colon cancer cell line. J
Biol Chem. 272:22199–22206. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Toyoshima H and Hunter T: p27, a novel
inhibitor of G1 cyclin-Cdk protein kinase activity, is related to
p21. Cell. 78:67–74. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yoon MK, Mitrea DM, Ou L and Kriwacki RW:
Cell cycle regulation by the intrinsically disordered proteins p21
and p27. Biochem Soc Trans. 40:981–988. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee TH, Chang HC, Chuang LY and Hung WC:
Involvement of PKA and Sp1 in the induction of p27(Kip1) by
tamoxifen. Biochem Pharmacol. 66:371–377. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Neto AG, McCutcheon IE, Vang R, Spencer
ML, Zhang W and Fuller GN: Elevated expression of p21 (WAF1/Cip1)
in hormonally active pituitary adenomas. Ann Diagn Pathol. 9:6–10.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Quinn BA, Dash R, Azab B, Sarkar S, Das
SK, Kumar S, Oyesanya RA, Dasgupta S, Dent P, Grant S, et al:
Targeting Mcl-1 for the therapy of cancer. Expert Opin Investig
Drugs. 20:1397–1411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tanaka C, Uzawa K, Shibahara T, Yokoe H,
Noma H and Tanzawa H: Expression of an inhibitor of apoptosis,
survivin, in oral carcinogenesis. J Dent Res. 82:607–611. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li H, Zhu H, Xu CJ and Yuan J: Cleavage of
BID by caspase 8 mediates the mitochondrial damage in the Fas
pathway of apoptosis. Cell. 94:491–501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Heibein JA, Goping IS, Barry M, Pinkoski
MJ, Shore GC, Green DR and Bleackley RC: Granzyme B-mediated
cytochrome c release is regulated by the Bcl-2 family members bid
and Bax. J Exp Med. 192:1391–1402. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kelekar A, Chang BS, Harlan JE, Fesik SW
and Thompson CB: Bad is a BH3 domain-containing protein that forms
an inactivating dimer with Bcl-XL. Mol Cell Biol. 17:7040–7046.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hsu SY, Kaipia A, Zhu L and Hsueh AJ:
Interference of BAD (Bcl-xL/Bcl-2-associated death
promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms
and P11. Mol Endocrinol. 11:1858–1867. 1997.PubMed/NCBI
|
|
49
|
Kharbanda S, Pandey P, Schofield L,
Israels S, Roncinske R, Yoshida K, Bharti A, Yuan ZM, Saxena S,
Weichselbaum R, et al: Role for Bcl-xL as an inhibitor of cytosolic
cytochrome C accumulation in DNA damage-induced apoptosis. Proc
Natl Acad Sci USA. 94:6939–6942. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Marzo I, Brenner C, Zamzami N, Susin SA,
Beutner G, Brdiczka D, Rémy R, Xie ZH, Reed JC and Kroemer G: The
permeability transition pore complex: A target for apoptosis
regulation by caspases and bcl-2-related proteins. J Exp Med.
187:1261–1271. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fulda S and Debatin KM: Extrinsic versus
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Beurel E and Jope RS: The paradoxical pro-
and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic
apoptosis signaling pathways. Prog Neurobiol. 79:173–189. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Moon DO, Park SY, Choi YH, Ahn JS and Kim
GY: Guggulsterone sensitizes hepatoma cells to TRAIL-induced
apoptosis through the induction of CHOP-dependent DR5: Involvement
of ROS-dependent ER-stress. Biochem Pharmacol. 82:1641–1650. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Luo X, Budihardjo I, Zou H, Slaughter C
and Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c
release from mitochondria in response to activation of cell surface
death receptors. Cell. 94:481–490. 1998. View Article : Google Scholar : PubMed/NCBI
|
